Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Compare Trans-Stomal Bladder Lithotripsy Methods in Continent Catheterizable Urinary Reservoirs

Official title: Comparison of Trans-Stomial Bladder Lithotripsy Using Mini-Percutaneous Equipment Versus Trans-stomial Bladder Lithotripsy Using Flexible Fibroscope, Percutaneous Approach and Open Cystolithotomy in Patients With Continent Catheterizable Urinary Reservoir

Run by Hospices Civils de Lyon · NCT07643454 · Data updated 2026-11-12

This study looks at different ways to break up bladder stones in people with continent catheterizable urinary diversions to see which method works best when the normal route isn’t available.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations2 sites (Lyon and 1 other locations)
StatusRecruiting
StartedOctober 19, 2026
Main results expectedFebruary 19, 2027
Study endsFebruary 19, 2027
Registry record updatedOctober 26, 2026
Trial IDNCT07643454 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with a continent catheterizable urinary diversion and a history of relevant cystolitholapaxy or lithotripsy via the continent stoma between 2015 and 2024.

Probably not a fit

Patients whose stones do not respond to a chosen lithotripsy method or those with complications unrelated to the procedure may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares trans-stomal bladder lithotripsy techniques using mini-percutaneous equipment, flexible fibroscope, percutaneous approaches, and open cystolithotomy in adults with continent catheterizable urinary reservoirs. It collects patient-reported outcomes via QoL-DUCC and Qualiveen questionnaires to gauge impact on quality of life and function. Eligible participants include adults with a history of relevant lithotripsy or endoscopic procedures through the continent stoma between 2015 and 2024. Sites are in Lyon, France, led by Hospices Civils de Lyon with two hospital locations. The study aims to document real-world practice patterns, safety, and patient-perceived outcomes to inform future recommendations.

Why it matters

Potential benefit: If successful, patients may experience safer, more effective stone management with improved quality of life.

How similar studies have gone: Prior reports describe multiple techniques and no single preferred approach, indicating variability and need for comparative data; this study adds observational insight rather than definitive efficacy evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient (aged 18 years or older)
* Patient with a catheterizable continent urinary diversion
* History of surgical intervention via vesicolithotomy, percutaneous cystolitholapaxy, trans-stomal cystolitholapaxy, or flexible endoscopic laser cystolithotripsy via the continent stoma between 01/01/2015 and 31/12/2024
* Patient has expressed non-opposition to participate in the research

Exclusion Criteria:

* Percutaneous or trans-stomal surgery for foreign body removal
* Postoperative follow-up period of less than 1 month after lithotripsy (Except for Clavien-Dindo Grade V cases)

Where it's running

  • Hôpital Edouard Herriot
    Lyon, France
    Recruiting
  • Hôpital Lyon Sud
    Pierre-Bénite, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.